• Modifi gets creative on the rocky road to a multibillion-dollar buyout

  • Nov 13 2024
  • Length: 24 mins
  • Podcast

Modifi gets creative on the rocky road to a multibillion-dollar buyout

Listen for free

View show details

  • Summary

  • Modifi Biosciences Inc. was recently acquired by Merck & Co. Inc. for $30 million up front. Modifi shareholders could receive milestones of up to $1.3 billion. It all happened in the dizzyingly short span of a little more than two years. Modifi’s founder, Ranjit Bindra, and a small group of advisers brought the company through preclinical work on DNA repair for treating glioblastoma and then twice faced running out of money and shutting down the company. Confounding the typical wisdom, Bindra and co-founder Kevin Rakin ended up putting the Merck deal together all by themselves. “People would actually ask, ‘Who is your banker that did the M&A deal?’ I said, ‘You're looking at them. It's me and Kevin Rakin.’ I learned a lot.” Bindra talks more about Modifi in the newest episode of the BioWorld Insider podcast.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Modifi gets creative on the rocky road to a multibillion-dollar buyout

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available